Science Explorer Back to mapMap
Discussion
Researcher · MultiMedica · Italy

Luca Ruggiero

Luca Ruggiero publishes mostly in Molecular Biology, Oncology and Cell Biology, on topics such as Cancer, Hypoxia, and Metabolism, Metabolism, Diabetes, and Cancer and Microtubule and mitosis dynamics.

ORCID 0000-0002-5914-7731 OpenAlex
World rank
#3,218,391
of 7,710,434 ranked researchers
Rank in Italy
#108,919
of 242,206
Works
23
Citations
919
Citations per work
40.0
h-index
6
i10-index 5Top 94% in Molecular Biology
Luca Ruggiero

What does Luca Ruggiero research?

Luca Ruggiero's work is mostly in Biochemistry, Genetics and Molecular Biology (51%), Medicine (21%), Health Professions (4%).

Life Sciences: 12 works · 50.8% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 50.8% of their workMolecular Biology: 7 works · 29.8% of their workCancer Research: 2 works · 10.5% of their workCell Biology: 2 works · 10.5% of their workHealth Sciences: 6 works · 24.6% of their workMedicine: 5 works · 21.1% of their workOncology: 3 works · 12.3% of their workPulmonary and Respiratory Medicine: 2 works · 8.8% of their workHealth Professions: 1 works · 3.5% of their workPhysical Therapy, Sports Therapy and Rehabilitation: 1 works · 3.5% of their workEverything else: 6 works · 24.6% of their workTHEIR WORKLuca Ruggiero23works
Life Sciences51%Health Sciences25%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1250.8%
    1. Medicine521.1%
    2. Health Professions13.5%
  3. Everything else624.6%
  1. 1Molecular Biology30% of their works
  2. 2Oncology12% of their works
  3. 3Cell Biology10% of their works
  4. 4Cancer Research10% of their works
  5. 5Pulmonary and Respiratory Medicine9% of their works
  6. 6Physical Therapy, Sports Therapy and Rehabilitation4% of their works

Research topics

Which keywords describe Luca Ruggiero's research?

The keywords of their largest research topics: Tumor Suppression, Cancer Therapy, Cancer, AMP-Activated Protein Kinase, HIF-1, Metformin, Warburg Effect and Cell Cycle.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Tumor Suppression72 topics
  2. Cancer Therapy62 topics
  3. Cancer52 topics
  4. AMP-Activated Protein Kinase41 topic
  5. HIF-141 topic
  6. Metformin41 topic
  7. Warburg Effect41 topic
  8. Cell Cycle31 topic
  9. Cell Division31 topic
  10. Development31 topic
  11. Microtubules31 topic
  12. Notch Signaling31 topic
  13. Signaling31 topic
  14. mTOR31 topic
  15. p5331 topic
  16. Endocytosis21 topic
  17. Fatty Acid Synthase21 topic
  18. Lipid Metabolism21 topic
  19. Membrane Fusion21 topic

Where does Luca Ruggiero work?

Luca Ruggiero's main affiliation in the publication record is MultiMedica, Italy.

How many publications and citations does Luca Ruggiero have?

OpenAlex counts 23 works and 919 citations for Luca Ruggiero, an h-index of 6, ranking #3,218,391 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Luca Ruggiero

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Luca Ruggiero. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.